Therefore, we used the γ-secretase inhibitor (GSI) Compound E [11] to downregulate NOTCH pathway signaling in the ALL-SIL cell-derived populations described above expressing three different levels of TLX1. The gene discussed is TLX1; the disease is acute lymphoblastic leukemia.